ENTRY       D01399                      Drug
NAME        Fentanyl citrate (JP18/USP);
            Abstral (TN);
            Fentora (TN);
            Lazanda (TN);
            Oralet (TN)
PRODUCT     ACTIQ (Cephalon)
            FENTANYL CITRATE (Akorn)
            FENTANYL CITRATE (Civica)
            FENTANYL CITRATE (Exela Pharma Sciences)
            FENTANYL CITRATE (Hikma Pharmaceuticals USA)
            FENTANYL CITRATE (Hospira)
            FENTANYL CITRATE (Hospira)
            FENTANYL CITRATE (Phlow Corp.)
            FENTORA (Cephalon)
  GENERIC   FENTANYL BUCCAL (Mayne Pharma)
            FENTANYL CITRATE (Fresenius Kabi USA)
            FENTANYL CITRATE (Fresenius Kabi USA)
            FENTANYL CITRATE (Hospira)
            FENTANYL CITRATE (SpecGx LLC)
            FENTANYL CITRATE (Teva Pharmaceuticals USA)
FORMULA     C22H28N2O. C6H8O7
EXACT_MASS  528.2472
MOL_WEIGHT  528.594
CLASS       Neuropsychiatric agent
             DG02030  Anesthetics
              DG02027  General anesthetics
               DG02026  Opioid anesthetics
             DG01564  Opioid receptor agonist
              DG01563  mu-Opioid receptor agonist
            Analgesic
             DG01984  Opioid analgesics
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 8219
            ATC code: N01AH01 N02AB03
            Chemical structure group: DG00791
            Product (DG00791): D00320<JP/US> D01399<JP/US>
EFFICACY    Analgesic (narcotic), Opioid receptor agonist
COMMENT     Phenylpiperidine derivative
TARGET      OPRM1 [HSA:4988] [KO:K04215]
  PATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07039  Opioid analgesics
            map07224  Opioid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01A ANESTHETICS, GENERAL
                N01AH Opioid anesthetics
                 N01AH01 Fentanyl
                  D01399  Fentanyl citrate (JP18/USP) &lt;JP/US&gt;
              N02 ANALGESICS
               N02A OPIOIDS
                N02AB Phenylpiperidine derivatives
                 N02AB03 Fentanyl
                  D01399  Fentanyl citrate (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Analgesics
              Opioid Analgesics, Long-acting
               Fentanyl
                D01399  Fentanyl citrate (JP18/USP)
              Opioid Analgesics, Short-acting
               Fentanyl
                D01399  Fentanyl citrate (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             8  Narcotics
              82  Non-alkaloidal narcotics
               821  Synthetic narcotics
                8219  Others
                 D01399  Fentanyl citrate (JP18/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG02026  Opioid anesthetics
                 DG00791  Fentanyl
                  D01399  Fentanyl citrate
              DG01564  Opioid receptor agonist
               DG01563  mu-Opioid receptor agonist
                DG00791  Fentanyl
                 D01399  Fentanyl citrate
             Analgesic
              DG01984  Opioid analgesics
               DG00791  Fentanyl
                D01399  Fentanyl citrate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00791  Fentanyl
                 D01399  Fentanyl citrate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Opioid
                OPRM1
                 D01399  Fentanyl citrate (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01399  Fentanyl citrate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01399
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01399
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG02026  Opioid anesthetics
                 DG00791  Fentanyl
              DG01564  Opioid receptor agonist
               DG01563  mu-Opioid receptor agonist
                DG00791  Fentanyl
             Analgesic
              DG01984  Opioid analgesics
               DG00791  Fentanyl
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00791  Fentanyl
DBLINKS     CAS: 990-73-8
            PubChem: 7848462
            ChEBI: 31602
            LigandBox: D01399
            NIKKAJI: J281.187A
ATOM        38
            1   C1d C    39.8723  -15.9084
            2   C1b C    38.6652  -16.6023
            3   C1b C    41.0794  -16.5964
            4   C6a C    40.5604  -14.6954
            5   O1a O    39.1666  -14.6954
            6   C6a C    37.4638  -15.9142
            7   C6a C    41.0677  -17.9902
            8   O6a O    39.8547  -13.4825
            9   O6a O    41.9600  -14.6954
            10  O6a O    36.2569  -16.6140
            11  O6a O    37.4522  -14.5205
            12  O6a O    42.2749  -18.6900
            13  O6a O    39.8547  -18.6840
            14  N1c N    25.4800  -15.0500
            15  C1y C    26.7400  -15.7500
            16  C8y C    24.2900  -15.7500
            17  C5a C    25.4800  -13.6500
            18  C1x C    26.7400  -17.1500
            19  C1x C    27.9300  -15.0500
            20  C8x C    23.1000  -15.0500
            21  C8x C    24.2900  -17.1500
            22  C1b C    26.7400  -12.9500
            23  O5a O    24.2900  -12.9500
            24  C1x C    27.9300  -17.8500
            25  C1x C    29.1200  -15.7500
            26  C8x C    21.8400  -15.7500
            27  C8x C    23.0300  -17.8500
            28  C1a C    27.9300  -13.6500
            29  N1y N    29.1200  -17.1500
            30  C8x C    21.8400  -17.0800
            31  C1b C    30.3800  -17.8500
            32  C1b C    31.5700  -17.1500
            33  C8y C    32.7600  -17.8500
            34  C8x C    32.7600  -19.2500
            35  C8x C    34.0200  -17.1500
            36  C8x C    34.0200  -19.9500
            37  C8x C    35.2100  -17.8500
            38  C8x C    35.2100  -19.2500
BOND        39
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 2
            9     6  10 1
            10    6  11 2
            11    7  12 1
            12    7  13 2
            13   14  15 1
            14   14  16 1
            15   14  17 1
            16   15  18 1
            17   15  19 1
            18   16  20 2
            19   16  21 1
            20   17  22 1
            21   17  23 2
            22   18  24 1
            23   19  25 1
            24   20  26 1
            25   21  27 2
            26   22  28 1
            27   24  29 1
            28   26  30 2
            29   29  31 1
            30   31  32 1
            31   32  33 1
            32   33  34 1
            33   33  35 2
            34   34  36 2
            35   35  37 1
            36   36  38 1
            37   25  29 1
            38   27  30 1
            39   37  38 2
///
